Report Puts Treatments for Low Back Pain in Jeopardy
American Society of Regional Anesthesia and Pain Medicine (ASRA)Thousands of patients with low-back pain could be left without access to potentially helpful treatments as a result of a recent study by the Agency for Healthcare Research and Quality (AHRQ) that is likely to influence reimbursement decision making. Pain specialists at the 14th Annual Pain Medicine Meeting in Miami, FL, this past week, explained why the “AHRQ Technology Assessment Report: Pain Management Injection Therapies for Low Back Pain” is flawed and steps that the American Society of Regional Anesthesia and Pain Medicine (ASRA), along with 13 other pain medicine groups, collectively known as the Multisociety Pain Workgroup (MPW) are taking to bring these concerns to regulatory groups.